AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 68 filers reported holding AVIDITY BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $909,329 | -54.1% | 142,528 | -20.3% | 0.00% | 0.0% |
| Q2 2023 | $1,982,138 | -49.3% | 178,732 | -29.8% | 0.00% | -66.7% |
| Q1 2023 | $3,907,665 | +53.3% | 254,571 | +121.7% | 0.00% | +50.0% |
| Q4 2022 | $2,548,411 | +129.0% | 114,845 | +68.5% | 0.00% | +100.0% |
| Q3 2022 | $1,113,000 | +36.2% | 68,161 | +21.2% | 0.00% | 0.0% |
| Q2 2022 | $817,000 | +59.9% | 56,245 | +103.3% | 0.00% | – |
| Q1 2022 | $511,000 | -70.8% | 27,662 | -62.5% | 0.00% | -100.0% |
| Q4 2021 | $1,753,000 | +20.3% | 73,741 | +24.7% | 0.00% | 0.0% |
| Q3 2021 | $1,457,000 | -43.6% | 59,145 | -43.5% | 0.00% | -50.0% |
| Q2 2021 | $2,585,000 | +54.9% | 104,627 | +36.8% | 0.00% | +100.0% |
| Q1 2021 | $1,669,000 | +1174.0% | 76,508 | +1392.8% | 0.00% | – |
| Q4 2020 | $131,000 | +469.6% | 5,125 | +538.2% | 0.00% | – |
| Q3 2020 | $23,000 | – | 803 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 889,957 | $16,438,000 | 14.87% |
| Aaron Wealth Advisors LLC | 3,984,902 | $215,750,000 | 2.99% |
| Cormorant Asset Management, LP | 2,012,115 | $37,164,000 | 2.85% |
| GREAT POINT PARTNERS LLC | 500,000 | $9,235,000 | 2.23% |
| RTW INVESTMENTS, LP | 4,795,000 | $88,564,000 | 1.83% |
| EcoR1 Capital, LLC | 2,759,505 | $50,968,000 | 1.59% |
| 5AM Venture Management, LLC | 390,555 | $7,214,000 | 1.58% |
| Altium Capital Management LP | 243,000 | $4,488,000 | 1.50% |
| Octagon Capital Advisors LP | 321,641 | $5,941,000 | 1.28% |
| Boxer Capital, LLC | 1,121,327 | $20,711,000 | 1.06% |